Project 2 - B cell antigen receptor structure and antigen-BCR interaction dynamics
项目2-B细胞抗原受体结构和抗原-BCR相互作用动力学
基本信息
- 批准号:10506668
- 负责人:
- 金额:$ 42.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-14 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAntibodiesAntibody ResponseAntigen ReceptorsAntigensAutologousB-Cell ActivationB-Cell Antigen ReceptorB-LymphocytesBindingBinding ProteinsBiochemicalBiophysicsCD4 Positive T LymphocytesCategoriesCell CommunicationCell LineCell membraneCell surfaceCellsCellular StructuresComplexCryoelectron MicroscopyDevelopmentDissociationDistalGoalsHIVHIV vaccineHIV-1IgEImmunobiologyImmunoglobulin DImmunoglobulin MImmunologicsLeadLigandsMHC Class II GenesMajor Histocompatibility ComplexMass Spectrum AnalysisMediatingMethodsModelingMolecularMolecular ConformationNaturePeptide/MHC ComplexPeptidesPolysaccharidesPropertyProteinsResolutionRestSignal TransductionSpecificityStructureVaccine DesignVaccinesVirusantigen bindingbasecell envelopedesigndimerenv Gene Productsexpectationneutralizing antibodyresponsesimulationstructural biologyvaccine efficacy
项目摘要
Project Summary/Abstract – Project 2
Structural analysis of how HIV-1 Envelope (Env) interacts with antigen receptor on B cells (BCR) to initiate B cell
signaling and activation is key to understanding antibody responses against HIV protein immunogens. Recent
studies of the organization of the BCR complex on the cell membrane supports a model in which BCRs exist in
different signaling states that require definition in structural terms. We hypothesize the following distinct states
of the BCR complex – 1) “signaling-inhibited’, 2) signaling-competent and 3) ‘signaling-disrupted’. Advances in
HIV-1 Env design including those that target germline precursors have led to the development of Env
immunogens as potential candidates for HIV vaccines. How BCRs of distinct specificities and signaling-states
interact with Env protein immunogens that trigger signaling and activate these cells are not clearly understood.
The overall goal of the project is to define BCR-antigen structures with specificity of broadly neutralizing
antibodies (bnAb), non-canonical glycan-binding bnAbs and to-be isolated autologous neutralizing antibodies
(anAb). In this project, we will perform biophysical/biochemical, structural and immunological analyses to define
properties of HIV Env-BCR interactions for activation of B cells expressing bnAb or germline precursor BCRs. In
Aim 1, we will perform Cryo-EM and molecular dynamic simulation analyses to define structures of antigen-
liganded BCR complex with specificities of autologous or broadly neutralizing HIV-1 antibodies. In addition, we
will define the structures of BCRs with specificities of glycan-binding bnAbs that present non-canonical Fab
configurations (I-shaped versus Y-shaped). In Aim 2, we will study specificity of bnAb precursors with disrupted
proximal signaling and determine whether such BCRs show distinct cell surface interaction dynamics with Env
proteins. Studies in Aim 3 will define antigen-BCR interaction parameters that enhance B cell signaling, antigen
internalization and MHC class II-peptide presentation of Env protein eptiopes. The proposed studies will bridge
high-resolution structures and antigen-BCR interaction dynamics to B cell signaling and activation. The long-
range goals of these studies are to provide the mechanistic basis for understanding the humoral response to
HIV-1 vaccines and guide development of strategies to enhance vaccine efficacy.
项目摘要/摘要-项目2
HIV-1膜蛋白(Env)与B细胞表面抗原受体(BCR)相互作用启动B细胞的结构分析
信号和激活是理解针对HIV蛋白免疫原的抗体反应的关键。近期
对细胞膜上BCR复合体组织的研究支持BCR存在于
需要在结构术语中定义的不同信令状态。我们假设了以下不同的状态
BCR复合体--1)“信令抑制”,2)“信令功能”和3)“信令中断”。最新进展
HIV-1环境设计,包括针对生殖系前体的设计,导致了环境的发展
免疫原作为艾滋病毒疫苗的潜在候选者。不同特性和信令状态的BCR如何
与Env蛋白免疫原相互作用,触发信号并激活这些细胞,目前还不清楚。
该项目的总体目标是确定具有广泛中和特异性的bcr抗原结构。
抗体(BNab)、非正规性糖链结合bNAbs和拟分离的自体中和抗体
(Anab)。在这个项目中,我们将进行生物物理/生化、结构和免疫学分析,以确定
HIV env-bcr相互作用激活表达bNab或生殖系前体bcr的B细胞的特性。在……里面
目标1,我们将进行冷冻-EM和分子动力学模拟分析来确定抗原的结构-
具有自身或广泛中和HIV-1抗体特异性的配基BCR复合体。此外,我们
将用呈现非规范Fab的糖链结合bNAbs的特异性来定义BCR的结构
配置(I型与Y型)。在目标2中,我们将研究受干扰的bNab前体的特异性
近端信号转导,并确定这种BCR是否显示出与Env明显的细胞表面相互作用动力学
蛋白质。AIM 3的研究将确定抗原-BCR相互作用参数,以增强B细胞信号转导,抗原
包膜蛋白表位的内化和MHC类II-肽递呈。拟议的研究将架起桥梁
高分辨结构和抗原-bcr相互作用动力学对B细胞信号和激活的影响。长的-
这些研究的范围目标是为理解体液反应提供机制基础。
艾滋病毒-1疫苗,并指导制定提高疫苗效力的战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
S. Munir ALAM其他文献
S. Munir ALAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('S. Munir ALAM', 18)}}的其他基金
Project 2 - B cell antigen receptor structure and antigen-BCR interaction dynamics
项目2-B细胞抗原受体结构和抗原-BCR相互作用动力学
- 批准号:
10643921 - 财政年份:2022
- 资助金额:
$ 42.81万 - 项目类别:
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
HIV-1 广泛中和抗体的 B 细胞受体的抗原识别和激活
- 批准号:
10338128 - 财政年份:2019
- 资助金额:
$ 42.81万 - 项目类别:
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
用于诱导 HIV 远端 gp41 广泛中和抗体的免疫原设计
- 批准号:
10597091 - 财政年份:2019
- 资助金额:
$ 42.81万 - 项目类别:
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
项目 2. 阐明用于诱导远端 MPER bnAb 的 Env 免疫原最佳序列的动物研究
- 批准号:
10597100 - 财政年份:2019
- 资助金额:
$ 42.81万 - 项目类别:
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
用于诱导 HIV 远端 gp41 广泛中和抗体的免疫原设计
- 批准号:
10132973 - 财政年份:2019
- 资助金额:
$ 42.81万 - 项目类别:
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
项目 2. 阐明用于诱导远端 MPER bnAb 的 Env 免疫原最佳序列的动物研究
- 批准号:
10365963 - 财政年份:2019
- 资助金额:
$ 42.81万 - 项目类别:
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
用于诱导 HIV 远端 gp41 广泛中和抗体的免疫原设计
- 批准号:
9912097 - 财政年份:2019
- 资助金额:
$ 42.81万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 42.81万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 42.81万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 42.81万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 42.81万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 42.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 42.81万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 42.81万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 42.81万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 42.81万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 42.81万 - 项目类别: